Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kerr

Showing results (611-620 of 966) with videos related to

Pageof 97
Sort By:
British Journal of Biomedical Science|July 31, 2010
Assessment of diabetic macrovascular complications: a prediabetes modelE U Nwose, R S Richards, S McDonald, et al.
Transplantation|November 1, 1989
Phenotypic definition of primed T cells in human renal allografts. Use of the CD45R markerA N Stein-Oakley, P G Kerr, N E Kraft, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Cardiovascular risk in dialysis patients: a comparison of risk factors and cardioprotective therapy between 1996 and 2001Fiona Y F Chow, Kevan R Polkinghorne, Steven J Chadban, et al.
European Journal of Immunology|April 27, 2012
Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIPMichelle M Collazo, Kim H T Paraiso, Mi-Young Park, et al.
Cancer Research|December 1, 1991
Phase I pharmacokinetic and pharmacodynamic study of a new anthrapyrazole, CI-937 (DUP937)C Erlichman, M Moore, I G Kerr, et al.
Kathmandu University Medical Journal (KUMJ)|December 9, 2015
BK Virus Associated Nephropathy, a Cause of Early Renal Allograft Dysfunction: A Single Centre StudyS Shrestha, P G Kerr, J Kanellis, et al.
Lancet (London, England)|May 27, 2016
Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practicesBruce M Robinson, Tadao Akizawa, Kitty J Jager, et al.
Nephrology (Carlton, Vic.)|May 11, 2016
The effect of holiday haemodialysis treatments on patient mood, adverse symptoms and subjective wellbeing using the Big Red Kidney BusJane Sims, Paul N Bennett, Cherene Ockerby, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1989
Reliable five-minute test strip method for identification of Streptococcus pyogenesS F Dealler, L Campbell, K G Kerr, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 12, 2010
Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practiceNigel D Toussaint, Eugenie Pedagogos, Jennifer Beavis, et al.
Pageof 97

Showing results (611-620 of 966) with videos related to

Sort By:
Pageof 97
British Journal of Biomedical Science|July 31, 2010
Assessment of diabetic macrovascular complications: a prediabetes modelE U Nwose, R S Richards, S McDonald, et al.
Transplantation|November 1, 1989
Phenotypic definition of primed T cells in human renal allografts. Use of the CD45R markerA N Stein-Oakley, P G Kerr, N E Kraft, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Cardiovascular risk in dialysis patients: a comparison of risk factors and cardioprotective therapy between 1996 and 2001Fiona Y F Chow, Kevan R Polkinghorne, Steven J Chadban, et al.
European Journal of Immunology|April 27, 2012
Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIPMichelle M Collazo, Kim H T Paraiso, Mi-Young Park, et al.
Cancer Research|December 1, 1991
Phase I pharmacokinetic and pharmacodynamic study of a new anthrapyrazole, CI-937 (DUP937)C Erlichman, M Moore, I G Kerr, et al.
Kathmandu University Medical Journal (KUMJ)|December 9, 2015
BK Virus Associated Nephropathy, a Cause of Early Renal Allograft Dysfunction: A Single Centre StudyS Shrestha, P G Kerr, J Kanellis, et al.
Lancet (London, England)|May 27, 2016
Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practicesBruce M Robinson, Tadao Akizawa, Kitty J Jager, et al.
Nephrology (Carlton, Vic.)|May 11, 2016
The effect of holiday haemodialysis treatments on patient mood, adverse symptoms and subjective wellbeing using the Big Red Kidney BusJane Sims, Paul N Bennett, Cherene Ockerby, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1989
Reliable five-minute test strip method for identification of Streptococcus pyogenesS F Dealler, L Campbell, K G Kerr, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 12, 2010
Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practiceNigel D Toussaint, Eugenie Pedagogos, Jennifer Beavis, et al.
Pageof 97